Related Experiment Video
Updated: Feb 27, 2026

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
Published on: April 14, 2016
The effects of analgesics on central processing of tonic pain: A cross-over placebo controlled study
Dina Lelic1, Tine M Hansen2, Esben B Mark3
1Mech-Sense, Department of Gastroenterology & Hepatology, Aalborg University Hospital, Aalborg, Denmark.
Introduction:
Opioids and antidepressants that inhibit serotonin and norepinephrine reuptake (SNRI) are recognized as analgesics to treat moderate to severe pain, but the central mechanisms underlying their analgesia remain unclear. This study investigated how brain activity at rest and exposed to tonic pain is modified by oxycodone (opioid) and venlafaxine (SNRI).
Methods:
Twenty healthy males were included in this randomized, cross-over, double-blinded study. 61-channel electroencephalogram (EEG) was recorded before and after five days of treatment with placebo, oxycodone (10 mg extended release b.i.d) or venlafaxine (37.5 mg extended release b.i.d) at rest and during tonic pain (hand immersed in 2 °C water for 80 s). Subjective pain and unpleasantness scores of tonic pain were recorded. Spectral analysis and sLORETA source localization were done in delta (1-4 Hz), theta (4-8 Hz), alpha (8-12 Hz), beta1 (12-18 Hz) and beta2 (18-32 Hz) frequency bands.
Results:
Oxycodone decreased pain and unpleasantness scores (P < 0.05), whereas venlafaxine decreased the pain scores (P < 0.05). None of the treatments changed the spectral indices or brain sources underlying resting EEG. Venlafaxine decreased spectral indices in alpha band of the EEG to tonic pain, whereas oxycodone decreased the spectral indices and brain source activity in delta and theta frequency bands (all P < 0.05). The brain source activity predominantly decreased in the insula and inferior frontal gyrus.
Conclusion:
The decrease of activity within insula and inferior frontal gyrus is likely involved in pain inhibition due to oxycodone treatment, whereas the decrease in alpha activity is likely involved in pain inhibition due to venlafaxine treatment.
Insights
Oxycodone and venlafaxine (SNRI) reduce pain through distinct brain mechanisms. Oxycodone affects delta and theta brainwaves in the insula and frontal gyrus, while venlafaxine impacts alpha waves during pain.
Area of Science:
- Neuroscience
- Pain Management
- Pharmacology
Background:
- Opioids and serotonin-norepinephrine reuptake inhibitors (SNRIs) are used for pain relief.
- Central mechanisms of analgesia for these drugs are not fully understood.
- This study examined brain activity changes induced by oxycodone and venlafaxine.
Purpose of the Study:
- To investigate the effects of oxycodone and venlafaxine on brain activity during rest and tonic pain.
- To elucidate the central mechanisms of analgesia for opioids and SNRIs.
Main Methods:
- A randomized, cross-over, double-blind study involving 20 healthy males.
- Electroencephalogram (EEG) recorded at rest and during tonic pain (cold water immersion).
- Analysis of spectral indices and source localization (sLORETA) across multiple frequency bands (delta, theta, alpha, beta).
Main Results:
- Both oxycodone and venlafaxine reduced subjective pain scores.
- Neither drug altered resting EEG spectral indices or brain sources.
- During tonic pain, venlafaxine decreased alpha band EEG activity.
- Oxycodone decreased delta and theta band EEG activity and associated brain source activity, particularly in the insula and inferior frontal gyrus.
Conclusions:
- Oxycodone's pain inhibition is linked to reduced activity in the insula and inferior frontal gyrus.
- Venlafaxine's pain inhibition is associated with decreased alpha band activity.
- Distinct neural pathways mediate analgesia for opioids and SNRIs.
More Related Videos
Related Concept Videos
Analgesia and Pain Management
Pain
Nociception
Opioid Analgesics: Synthetic and Semisynthetic Opioids

